PRC2 during vertebrate organogenesis: A complex in transition

Developmental Biology

Volumn 367, Issue 2, 2012, Pages 91-99

  Aldiri, Issam ^a   Vetter, Monica L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cell fate; Differentiation; Epigenetics; Histone methyltransferase; Polycomb; PRC2

Indexed keywords

HISTONE H3; POLYCOMB GROUP PROTEIN; POLYCOMB REPRESSIVE COMPLEX 1; POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EZH1; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG;

BINDING AFFINITY; BINDING SITE; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DEVELOPMENTAL GENE; EMBRYO DEVELOPMENT; ENHANCER OF ZESTE HOMOLOG 1 GENE; ENHANCER OF ZESTE HOMOLOG 2 GENE; ENZYME ACTIVITY; EPIGENETICS; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; HISTONE METHYLATION; MOLECULAR DYNAMICS; MUSCLE DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; ORGANOGENESIS; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

VERTEBRATA;

EID: 84862154100     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2012.04.030     Document Type: Review

References (115)

1. Akasaka T., Kanno M., Balling R., Mieza M.A., Taniguchi M., Koseki H. A role for mel-18, a Polycomb group-related vertebrate gene, during theanteroposterior specification of the axial skeleton. Development 1996, 122:1513-1522.
2. Akizu N., Estaras C., Guerrero L., Marti E., Martinez-Balbas M.A. H3K27me3 regulates BMP activity in developing spinal cord. Development 2010, 137:2915-2925.
3. Aldiri I., Vetter M.L. Characterization of the expression pattern of the PRC2 core subunit Suz12 during embryonic development of Xenopus laevis. Dev. Dyn. 2009, 238:3185-3192.
4. Alexander T., Nolte C., Krumlauf R. Hox genes and segmentation of the hindbrain and axial skeleton. Annu. Rev. Cell Dev. Biol. 2009, 25:431-456.
5. Aoki R., Chiba T., Miyagi S., Negishi M., Konuma T., Taniguchi H., Ogawa M., Yokosuka O., Iwama A. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells. J. Hepatol. 2010, 52:854-863.
6. Arai D., Katsura H., Shindo N., Matsumoto M., Higashinakagawa T. Polycomb group protein Ezh1 represses Nodal and maintains the left-right axis. Dev. Biol. 2010, 341:459-463.
7. Benoit Y.D., Lepage M.B., Khalfaoui T., Tremblay E., Basora N., Carrier J.C., Gudas L.J., Beaulieu J.F. Polycomb repressive complex 2 impedes intestinal cell terminal differentiation. J. Cell Sci. 2012.
8. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
9. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., Feil R., Schreiber S.L., Lander E.S. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125:315-326.
10. Boyer L.A., Plath K., Zeitlinger J., Brambrink T., Medeiros L.A., Lee T.I., Levine S.S., Wernig M., Tajonar A., Ray M.K., Bell G.W., Otte A.P., Vidal M., Gifford D.K., Young R.A., Jaenisch R. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006, 441:349-353.
11. Bracken A.P., Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 2009, 9:773-784.
12. Bracken A.P., Pasini D., Capra M., Prosperini E., Colli E., Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 2003, 22:5323-5335.
13. Bryant R.J., Winder S.J., Cross S.S., Hamdy F.C., Cunliffe V.T. The Polycomb Group protein EZH2 regulates actin polymerization in human prostate cancer cells. Prostate 2008, 68:255-263.
14. Burgold T., Spreafico F., De Santa F., Totaro M.G., Prosperini E., Natoli G., Testa G. The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural commitment. PloS One 2008, 3:e3034.
15. Cao R., Tsukada Y., Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 2005, 20:845-854.
16. Caretti G., Di Padova M., Micales B., Lyons G.E., Sartorelli V. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev. 2004, 18:2627-2638.
17. Caretti G., Palacios D., Sartorelli V., Puri P.L. Phosphoryl-EZH-ion. Cell Stem Cell 2011, 8:262-265.
18. Cha T.L., Zhou B.P., Xia W., Wu Y., Yang C.C., Chen C.T., Ping B., Otte A.P., Hung M.C. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 2005, 310:306-310.
19. Chamberlain S.J., Yee D., Magnuson T. Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells 2008, 26:1496-1505.
20. Chen H., Gu X., Su I.H., Bottino R., Contreras J.L., Tarakhovsky A., Kim S.K. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev. 2009, 23:975-985.
21. Chen L., Ma Y., Kim E.Y., Yu W., Schwartz R.J., Qian L., Wang J. Conditional ablation of Ezh2 in murine hearts reveals its essential roles in endocardial cushion formation, cardiomyocyte proliferation and survival. PloS One 2012, 7:e31005.
22. Chen S., Bohrer L.R., Rai A.N., Pan Y., Gan L., Zhou X., Bagchi A., Simon J.A., Huang H. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat. Cell Biol. 2010, 12:1108-1114.
23. Chi P., Allis C.D., Wang G.G. Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 2010, 10:457-469.
24. Chou R.H., Yu Y.L., Hung M.C. The roles of EZH2 in cell lineage commitment. Am. J. Transl. Res. 2011, 3:243-250.
25. del Mar Lorente M., Marcos-Gutierrez C., Perez C., Schoorlemmer J., Ramirez A., Magin T., Vidal M. Loss- and gain-of-function mutations show a polycomb group function for Ring1A in mice. Development 2000, 127:5093-5100.
26. Delgado-Olguin P., Huang Y., Li X., Christodoulou D., Seidman C.E., Seidman J.G., Tarakhovsky A., Bruneau B.G. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat. Genet. 2012, 44:343-347.
27. Ezhkova E., Lien W.H., Stokes N., Pasolli H.A., Silva J.M., Fuchs E. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev. 2011, 25:485-498.
28. Ezhkova E., Pasolli H.A., Parker J.S., Stokes N., Su I.H., Hannon G., Tarakhovsky A., Fuchs E. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 2009, 136:1122-1135.
29. Fasano C.A., Dimos J.T., Ivanova N.B., Lowry N., Lemischka I.R., Temple S. shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell 2007, 1:87-99.
30. Faust C., Lawson K.A., Schork N.J., Thiel B., Magnuson T. The Polycomb-group gene eed is required for normal morphogenetic movements during gastrulation in the mouse embryo. Development 1998, 125:4495-4506.
31. Fischle W., Wang Y., Jacobs S.A., Kim Y., Allis C.D., Khorasanizadeh S. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev. 2003, 17:1870-1881.
32. Fullgrabe J., Kavanagh E., Joseph B. Histone onco-modifications. Oncogene 2011, 30:3391-3403.
33. He A., Ma Q., Cao J., von Gise A., Zhou P., Xie H., Zhang B., Hsing M., Christodoulou D., Cahan P., Daley G.Q., Kong S.W., Orkin S.H., Seidman C.E., Seidman J.G., Pu W.T. Polycomb repressive complex 2 regulates normal development of the mouse heart. Circ. Res. 2011, 110:406-415.
34. Hirabayashi Y., Gotoh Y. Epigenetic control of neural precursor cell fate during development. Nat. Rev. Neurosci. 2010, 11:377-388.
35. Hirabayashi Y., Suzki N., Tsuboi M., Endo T.A., Toyoda T., Shinga J., Koseki H., Vidal M., Gotoh Y. Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition. Neuron 2009, 63:600-613.
36. Ho L., Crabtree G.R. An EZ mark to miss. Cell Stem Cell 2008, 3:577-578.
37. Juan A.H., Derfoul A., Feng X., Ryall J.G., Dell'Orso S., Pasut A., Zare H., Simone J.M., Rudnicki M.A., Sartorelli V. Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells. Genes Dev. 2011, 25:789-794.
38. Juan A.H., Kumar R.M., Marx J.G., Young R.A., Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol. Cell 2009, 36:61-74.
39. Kaneko S., Li G., Son J., Xu C.F., Margueron R., Neubert T.A., Reinberg D. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 2010, 24:2615-2620.
40. Ketel C.S., Andersen E.F., Vargas M.L., Suh J., Strome S., Simon J.A. Subunit contributions to histone methyltransferase activities of fly and worm polycomb group complexes. Mol. Cell Biol. 2005, 25:6857-6868.
41. Kim H., Kang K., Ekram M.B., Roh T.Y., Kim J. Aebp2 as an epigenetic regulator for neural crest cells. PloS One 2011, 6:e25174.
42. Kleer C.G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S.A., Ghosh D., Sewalt R.G., Otte A.P., Hayes D.F., Sabel M.S., Livant D., Weiss S.J., Rubin M.A., Chinnaiyan A.M. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA 2003, 100:11606-11611.
43. Ku M., Koche R.P., Rheinbay E., Mendenhall E.M., Endoh M., Mikkelsen T.S., Presser A., Nusbaum C., Xie X., Chi A.S., Adli M., Kasif S., Ptaszek L.M., Cowan C.A., Lander E.S., Koseki H., Bernstein B.E. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet. 2008, 4:e1000242.
44. Kuzmichev A., Margueron R., Vaquero A., Preissner T.S., Scher M., Kirmizis A., Ouyang X., Brockdorff N., Abate-Shen C., Farnham P., Reinberg D. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc. Natl. Acad. Sci. USA 2005, 102:1859-1864.
45. Kuzmichev A., Nishioka K., Erdjument-Bromage H., Tempst P., Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 2002, 16:2893-2905.
46. Lan F., Bayliss P.E., Rinn J.L., Whetstine J.R., Wang J.K., Chen S., Iwase S., Alpatov R., Issaeva I., Canaani E., Roberts T.M., Chang H.Y., Shi Y. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 2007, 449:689-694.
47. Landeira D., Fisher A.G. Inactive yet indispensable: the tale of Jarid2. Trends Cell Biol. 2010, 21:74-80.
48. Landeira D., Sauer S., Poot R., Dvorkina M., Mazzarella L., Jorgensen H.F., Pereira C.F., Leleu M., Piccolo F.M., Spivakov M., Brookes E., Pombo A., Fisher C., Skarnes W.C., Snoek T., Bezstarosti K., Demmers J., Klose R.J., Casanova M., Tavares L., Brockdorff N., Merkenschlager M., Fisher A.G. Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators. Nat. Cell Biol. 2010, 12:618-624.
49. Lee S., Lee J.W., Lee S.K. UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program. Dev. Cell 2012, 22:25-37.
50. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., Chevalier B., Johnstone S.E., Cole M.F., Isono K., Koseki H., Fuchikami T., Abe K., Murray H.L., Zucker J.P., Yuan B., Bell G.W., Herbolsheimer E., Hannett N.M., Sun K., Odom D.T., Otte A.P., Volkert T.L., Bartel D.P., Melton D.A., Gifford D.K., Jaenisch R., Young R.A. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006, 125:301-313.
51. Leeb M., Pasini D., Novatchkova M., Jaritz M., Helin K., Wutz A. Polycomb complexes act redundantly to repress genomic repeats and genes. Genes Dev. 2010, 24:265-276.
52. Li G., Margueron R., Ku M., Chambon P., Bernstein B.E., Reinberg D. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev. 2010, 24:368-380.
53. Li X., Gonzalez M.E., Toy K., Filzen T., Merajver S.D., Kleer C.G. Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia. Am. J. Pathol. 2009, 175:1246-1254.
54. Lim D.A., Huang Y.C., Swigut T., Mirick A.L., Garcia-Verdugo J.M., Wysocka J., Ernst P., Alvarez-Buylla A. Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 2009, 458:529-533.
55. Margueron R., Justin N., Ohno K., Sharpe M.L., Son J., Drury W.J., Voigt P., Martin S.R., Taylor W.R., De Marco V., Pirrotta V., Reinberg D., Gamblin S.J. Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 2009, 461:762-767.
56. Margueron R., Li G., Sarma K., Blais A., Zavadil J., Woodcock C.L., Dynlacht B.D., Reinberg D. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol. Cell 2008, 32:503-518.
57. Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
58. Martinez A.M., Cavalli G. The role of polycomb group proteins in cell cycle regulation during development. Cell Cycle 2006, 5:1189-1197.
59. Molofsky A.V., He S., Bydon M., Morrison S.J., Pardal R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 2005, 19:1432-1437.
60. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425:962-967.
61. Muller H., Bracken A.P., Vernell R., Moroni M.C., Christians F., Grassilli E., Prosperini E., Vigo E., Oliner J.D., Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 2001, 15:267-285.
62. Muller J., Hart C.M., Francis N.J., Vargas M.L., Sengupta A., Wild B., Miller E.L., O'Connor M.B., Kingston R.E., Simon J.A. Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell 2002, 111:197-208.
63. Nekrasov M., Klymenko T., Fraterman S., Papp B., Oktaba K., Kocher T., Cohen A., Stunnenberg H.G., Wilm M., Muller J. Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes. EMBO J. 2007, 26:4078-4088.
64. Neri F., Zippo A., Krepelova A., Cherubini A., Rocchigiani M., Oliviero S. Myc regulates the transcription of PRC2 to control the expression of developmental genes in embryonic stem cells. Mol. Cell Biol. 2011, 32:840-851.
65. Ng S.Y., Johnson R., Stanton L.W. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J. 2012, 31:522-533.
66. O'Carroll D., Erhardt S., Pagani M., Barton S.C., Surani M.A., Jenuwein T. The polycomb-group gene Ezh2 is required for early mouse development. Mol. Cell Biol. 2001, 21:4330-4336.
67. Orzan F., Pellegatta S., Poliani P.L., Pisati F., Caldera V., Menghi F., Kapetis D., Marras C., Schiffer D., Finocchiaro G. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells. Neuropathol. Appl. Neurobiol. 2011, 37:381-394.
68. Palacios D., Mozzetta C., Consalvi S., Caretti G., Saccone V., Proserpio V., Marquez V.E., Valente S., Mai A., Forcales S.V., Sartorelli V., Puri P.L. TNF/p38alpha/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010, 7:455-469.
69. Pasini D., Bracken A.P., Hansen J.B., Capillo M., Helin K. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell Biol. 2007, 27:3769-3779.
70. Pasini D., Bracken A.P., Jensen M.R., Lazzerini Denchi E., Helin K. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J. 2004, 23:4061-4071.
71. Pauli A., Rinn J.L., Schier A.F. Non-coding RNAs as regulators of embryogenesis. Nat. Rev. Genet. 2011, 12:136-149.
72. Pedersen M.T., Helin K. Histone demethylases in development and disease. Trends Cell Biol. 2010, 20:662-671.
73. Peng J.C., Valouev A., Swigut T., Zhang J., Zhao Y., Sidow A., Wysocka J. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 2009, 139:1290-1302.
74. Pereira J.D., Sansom S.N., Smith J., Dobenecker M.W., Tarakhovsky A., Livesey F.J. Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex. Proc. Natl. Acad. Sci. USA 2010, 107:15957-15962.
75. Pietersen A.M., van Lohuizen M. Stem cell regulation by polycomb repressors: postponing commitment. Curr. Opin. Cell Biol. 2008, 20:201-207.
76. Pirrotta V. Polycomb repression under the skin. Cell 2009, 136:992-994.
77. Prezioso C., Orlando V. Polycomb proteins in mammalian cell differentiation and plasticity. FEBS Lett. 2011, 585:2067-2077.
78. Rao R.C., Tchedre K.T., Malik M.T., Coleman N., Fang Y., Marquez V.E., Chen D.F. Dynamic patterns of histone lysine methylation in the developing retina. Invest. Ophthalmol. Vis. Sci. 2010, 51:6784-6792.
79. Rapicavoli N.A., Poth E.M., Zhu H., Blackshaw S. The long noncoding RNA Six3OS acts in trans to regulate retinal development by modulating Six3 activity. Neural Dev. 2011, 6:32.
80. Richie E.R., Schumacher A., Angel J.M., Holloway M., Rinchik E.M., Magnuson T. The Polycomb-group gene eed regulates thymocyte differentiation and suppresses the development of carcinogen-induced T-cell lymphomas. Oncogene 2002, 21:299-306.
81. Richly H., Aloia L., Di Croce L. Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis. 2011, 2:e204.
82. Riising E.M., Boggio R., Chiocca S., Helin K., Pasini D. The polycomb repressive complex 2 is a potential target of SUMO modifications. PloS One 2008, 3:e2704.
83. Ringrose L., Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 2004, 38:413-443.
84. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
85. Sawarkar R., Paro R. Interpretation of developmental signaling at chromatin: the Polycomb perspective. Dev. Cell 2010, 19:651-661.
86. Schmitges F.W., Prusty A.B., Faty M., Stutzer A., Lingaraju G.M., Aiwazian J., Sack R., Hess D., Li L., Zhou S., Bunker R.D., Wirth U., Bouwmeester T., Bauer A., Ly-Hartig N., Zhao K., Chan H., Gu J., Gut H., Fischle W., Muller J., Thoma N.H. Histone methylation by PRC2 is inhibited by active chromatin marks. Mol. Cell 2011, 42:330-341.
87. Schwartz Y.B., Kahn T.G., Nix D.A., Li X.Y., Bourgon R., Biggin M., Pirrotta V. Genome-wide analysis of Polycomb targets in Drosophila melanogaster. Nat. Genet. 2006, 38:700-705.
88. Schwartzentruber J., Korshunov A., Liu X.Y., Jones D.T., Pfaff E., Jacob K., Sturm D., Fontebasso A.M., Quang D.A., Tonjes M., Hovestadt V., Albrecht S., Kool M., Nantel A., Konermann C., Lindroth A., Jager N., Rausch T., Ryzhova M., Korbel J.O., Hielscher T., Hauser P., Garami M., Klekner A., Bognar L., Ebinger M., Schuhmann M.U., Scheurlen W., Pekrun A., Fruhwald M.C., Roggendorf W., Kramm C., Durken M., Atkinson J., Lepage P., Montpetit A., Zakrzewska M., Zakrzewski K., Liberski P.P., Dong Z., Siegel P., Kulozik A.E., Zapatka M., Guha A., Malkin D., Felsberg J., Reifenberger G., von Deimling A., Ichimura K., Collins V.P., Witt H., Milde T., Witt O., Zhang C., Castelo-Branco P., Lichter P., Faury D., Tabori U., Plass C., Majewski J., Pfister S.M., Jabado N. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012, 482:226-231.
89. Seenundun S., Rampalli S., Liu Q.C., Aziz A., Palii C., Hong S., Blais A., Brand M., Ge K., Dilworth F.J. UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis. EMBO J. 2010, 29:1401-1411.
90. Sen G.L., Webster D.E., Barragan D.I., Chang H.Y., Khavari P.A. Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev. 2008, 22:1865-1870.
91. Shen X., Kim W., Fujiwara Y., Simon M.D., Liu Y., Mysliwiec M.R., Yuan G.C., Lee Y., Orkin S.H. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009, 139:1303-1314.
92. Shen X., Liu Y., Hsu Y.J., Fujiwara Y., Kim J., Mao X., Yuan G.C., Orkin S.H. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol. Cell 2008, 32:491-502.
93. Sher F., Rossler R., Brouwer N., Balasubramaniyan V., Boddeke E., Copray S. Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells 2008, 26:2875-2883.
94. Shi B., Liang J., Yang X., Wang Y., Zhao Y., Wu H., Sun L., Zhang Y., Chen Y., Li R., Zhang Y., Hong M., Shang Y. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol. Cell Biol. 2007, 27:5105-5119.
95. Simon J.A., Kingston R.E. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 2009, 10:697-708.
96. Sing A., Pannell D., Karaiskakis A., Sturgeon K., Djabali M., Ellis J., Lipshitz H.D., Cordes S.P. A vertebrate Polycomb response element governs segmentation of the posterior hindbrain. Cell 2009, 138:885-897.
97. Singh K., Dilworth F.J. Redirecting traffic in the nucleus. Dev. Cell 2011, 21:390-392.
98. Snowden A.W., Gregory P.D., Case C.C., Pabo C.O. Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo. Curr. Biol. 2002, 12:2159-2166.
99. Sparmann A., van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 2006, 6:846-856.
100. Spivakov M., Fisher A.G. Epigenetic signatures of stem-cell identity. Nat. Rev. Genet. 2007, 8:263-271.
101. Stojic L., Jasencakova Z., Prezioso C., Stutzer A., Bodega B., Pasini D., Klingberg R., Mozzetta C., Margueron R., Puri P.L., Schwarzer D., Helin K., Fischle W., Orlando V. Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells. Epigenet. Chromatin 2011, 4:16.
102. Su I.H., Basavaraj A., Krutchinsky A.N., Hobert O., Ullrich A., Chait B.T., Tarakhovsky A. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 2003, 4:124-131.
103. Su I.H., Dobenecker M.W., Dickinson E., Oser M., Basavaraj A., Marqueron R., Viale A., Reinberg D., Wulfing C., Tarakhovsky A. Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell 2005, 121:425-436.
104. Surface L.E., Thornton S.R., Boyer L.A. Polycomb group proteins set the stage for early lineage commitment. Cell Stem Cell 2010, 7:288-298.
105. Testa G. The time of timing: how Polycomb proteins regulate neurogenesis. Bioessays 2011, 33:519-528.
106. Turner B.M. Defining an epigenetic code. Nat. Cell Biol. 2007, 9:2-6.
107. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., Chinnaiyan A.M. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002, 419:624-629.
108. Wang J., Kumar R.M., Biggs V.J., Lee H., Chen Y., Kagey M.H., Young R.A., Abate-Shen C. The Msx1 homeoprotein recruits polycomb to the nuclear periphery during development. Dev. Cell 2011, 21:575-588.
109. Wang L., Jin Q., Lee J.E., Su I.H., Ge K. Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis. Proc. Natl. Acad. Sci. USA 2010, 107:7317-7322.
110. Wei Y., Chen Y.H., Li L.Y., Lang J., Yeh S.P., Shi B., Yang C.C., Yang J.Y., Lin C.Y., Lai C.C., Hung M.C. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat. Cell Biol. 2011, 13:87-94.
111. Wu G., Broniscer A., McEachron T.A., Lu C., Paugh B.S., Becksfort J., Qu C., Ding L., Huether R., Parker M., Zhang J., Gajjar A., Dyer M.A., Mullighan C.G., Gilbertson R.J., Mardis E.R., Wilson R.K., Downing J.R., Ellison D.W., Baker S.J. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 2012, 44:251-253.
112. Wyngaarden L.A., Delgado-Olguin P., Su I.H., Bruneau B.G., Hopyan S. Ezh2 regulates anteroposterior axis specification and proximodistal axis elongation in the developing limb. Development 2011, 138:3759-3767.
113. Xu C.R., Cole P.A., Meyers D.J., Kormish J., Dent S., Zaret K.S. Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science 2011, 332:963-966.
114. Yuzyuk T., Fakhouri T.H., Kiefer J., Mango S.E. The polycomb complex protein mes-2/E(z) promotes the transition from developmental plasticity to differentiation in C. elegans embryos. Dev. Cell 2009, 16:699-710.
115. Zeng X., Chen S., Huang H. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions. Cell Cycle 2011, 10:579-583.